Blog
RSS FeedPosted by Michael Wonder on 12 May 2018
Americans, tired of high-priced drugs, are fighting back
10 May 2018 - If one concern unites Americans, it is the high prices of prescription drugs. One incident in particular ...
Posted by Michael Wonder on 12 May 2018
PhRMA statement on President Trump’s drug pricing blueprint
11 May 2018 - Pharmaceutical Research and Manufacturers of America president and CEO Stephen J. Ubl issued the following statement ...
Posted by Michael Wonder on 12 May 2018
ASHP response to President Trump's speech on prescription drug prices
11 May 2018 - President Trump unveiled the outlines of his "American Patients First" blueprint to address high drug prices. ...
Posted by Michael Wonder on 12 May 2018
Statement from FDA Commissioner on the Trump Administration’s plan to lower drug prices
11 May 2018 - Today is an important day in the Administration’s collaborative effort to address the rising cost of ...
Posted by Michael Wonder on 12 May 2018
FDA expands approval of Gilenya to treat multiple sclerosis in paediatric patients
11 May 2018 - The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in ...
Posted by Michael Wonder on 11 May 2018
Drug makers' answer on drug prices: hold free-riding foreign governments accountable
10 May 2018 - Global trade with the U.S. has helped more people all over the world get lifesaving medicines. But ...
Posted by Michael Wonder on 10 May 2018
Games and greed delay the market entry of money-saving biosimilars
9 May 2018 - Generic medicines have saved Americans $1.67 trillion in the last decade. ...
Posted by Michael Wonder on 10 May 2018
AcelRx resubmits new drug application for Dsuvia
9 May 2018 - AcelRx Pharmaceuticals today announced the resubmission of the new drug application for DSUVIA with the U.S. ...
Posted by Michael Wonder on 10 May 2018
To lower drug costs at home, Trump wants higher prices abroad
9 May 2018 - People who work in the industry said it was unlikely that consumers would go to the pharmacy ...
Posted by Michael Wonder on 09 May 2018
Forty Seven granted fast track designation for 5F9 for the treatment of diffuse large B-cell lymphoma and follicular lymphoma
3 May 2018 - Forty Seven today announced that the U.S. FDA has granted two fast track designations to its lead ...
Posted by Michael Wonder on 09 May 2018
Evaluating and valuing drugs for rare conditions: no easy answers
9 May 2018 - We find ourselves in an era of unprecedented growth in the development and use of so-called “orphan” ...
Posted by Michael Wonder on 09 May 2018
FDA grants fast track designation to Debiopharm's Debio 1347 for the treatment of patients with unresectable or metastatic tumours with a specific FGFR gene alteration
8 May 2018 - Debiopharm announced today that the U.S. FDA has granted fast track designation to Debio 1347, an ...
Posted by Michael Wonder on 09 May 2018
Relypsa announces FDA approval of supplemental new drug application to enable the usage of Veltassa (patiromer) with or without food
8 May 2018 - Updated label may allow for increased dosing flexibility for patients with hyperkalaemia – a chronic, asymptomatic condition ...
Posted by Michael Wonder on 09 May 2018
Transparency on quality and price will transform medicine
9 May 2018 - Transparency is becoming a fashionable buzzword in many walks of life. ...
Posted by Michael Wonder on 09 May 2018
Aligning price and value for drugs—potential disrupters of the PBM model
7 May 2018 - When the latest version of the iPhone comes out, customers can judge whether the price is "worth ...